Document is current
Any future updates will be listed below
-
Authors
Rainio, Oona https://orcid.org/0000-0002-7775-7656
Kärpijoki, Henri
Nesterov, Sergey V. https://orcid.org/0000-0002-6549-8749
Klén, Riku https://orcid.org/0000-0002-0982-8360
Knuuti, Juhani https://orcid.org/0000-0003-3156-9593
-
Funding
Funding for this research was provided by:
University of Turku
- License Information
-
More Information
Article History
Received: 9 May 2026
Accepted: 3 August 2026
First Online: 26 August 2026
Declarations
Competing interests: J.K. received consultation fees from GE Healthcare and AstraZeneca and speaker fees from GE Healthcare, Bayer, Lundbeck, Boehringer-Ingelheim, Pfizer, Merck, and Siemens, outside the submitted work.
Ethics approval: The research was approved by Ethics Committee of the Hospital District of Southwest Finland (permit: VARHA/3940/13.02.02/2023).
Consent to participate: All the patients were at least 18 years of age and gave informed written consent to the research from their data.
Consent to publish: All the participants consented to publishing their data in research.
